ELUT: Elutia Inc. Stock

by  •  • Comments Off on ELUT: Elutia Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 79.87
Enterprise Value ($M) 95.23
Book Value ($M) -50.30
Book Value / Share -2.07
Price / Book -1.59
NCAV ($M) -61.67
NCAV / Share -2.53
Price / NCAV -1.29

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.79
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.55
Current Ratio 0.63

Balance Sheet (mrq) ($M)
Current Assets 23.99
Assets 35.36
Liabilities 85.66
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 24.75
Operating Income -20.54
Net Income -37.66

Cash Flow Statement (mra) ($M)
Cash From Operations -21.76
Cash from Investing 14.21
Cash from Financing 9.84

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-20 13G/A Birchview Capital, LP 8.76 0.00
02-14 13G Nantahala Capital Management, LLC 9.90
02-07 13G/A Hirschman Orin 9.90 0.91
01-09 13D/A HighCape Capital, L.P. 48.70 -28.09

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-13 26,437 65,062 40.63
2024-05-10 26,064 11,971 217.73
2024-05-09 338 3,430 9.85
2024-05-08 748 254 294.49

(click for more detail)

Similar Companies
EDSA – Edesa Biotech, Inc. EFTR – eFFECTOR Therapeutics, Inc.
ELDN – Eledon Pharmaceuticals, Inc. ENLV – Enlivex Therapeutics Ltd.
ENSC – Ensysce Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io